How to read a pathology report you don't understand

Short answer: A pathology report tells you what the tissue actually is (diagnosis), how aggressive it looks (grade), how far it has spread in the sample (stage / margins), and any molecular markers that change treatment. Below is a plain-language walk-through of each section and what to ask your doctor about it.

A pathology report is often the first piece of paper that makes a diagnosis feel real — and it's usually written for other doctors, not for you. Terms like "invasive," "margins," "grade," and "receptor status" carry enormous weight, but nothing in the document explains what they actually mean for your specific situation.

If you're holding one right now and trying to figure out what it says, here's a plain-language walk-through of what's typically in one, what the most common terms mean, and what to do if yours still doesn't make sense.

What a pathology report actually is

A pathology report is written by a pathologist — a doctor who examines tissue, cells, or fluid under a microscope. When a biopsy, surgery, or fluid sample is taken, it goes to the pathology lab, where the pathologist studies it and writes up what they see. That report becomes the primary evidence for what your diagnosis is.

Your treating doctor (oncologist, surgeon, primary care physician) uses the pathology report to decide what to do next. That's why the words on it matter so much — every treatment recommendation you're about to hear traces back to this document.

The American Cancer Society's guide to pathology reports is a good companion piece if you want to go deeper on any of the sections below.

The basic sections you'll usually see

Specimen information. This describes what tissue was examined and where it came from. It's mostly administrative, but worth confirming it matches what you expected — the correct side (left vs. right), the correct location, the correct patient. Errors here are rare but not unheard of.

Clinical history. A short line or two about why the sample was taken — for example, "55-year-old woman with abnormal mammogram." This is context for the pathologist, not a diagnosis.

Gross description. What the tissue looked like to the naked eye before being processed — size, color, texture. Often written in technical language but rarely important for the patient.

Microscopic description. What the pathologist saw under the microscope. This is where the diagnostic reasoning lives, and it can be dense — cell shapes, patterns, staining results. Skim, don't dwell.

Diagnosis. This is the core of the report — the specific name of what was found. This single line often gets the most attention and the least explanation. If a term here is unfamiliar, that's the first thing worth asking about directly. The NCI Dictionary of Cancer Terms is a reliable place to look up individual words in plain English.

Tumor characteristics (if applicable). This section may include size, grade, and margins. More on each below. The College of American Pathologists' patient guide explains how these are measured.

Receptor or biomarker status (common in cancer pathology). These results — like hormone receptor status in breast cancer, or genetic markers like KRAS in colon cancer — often determine which treatments will actually work. This section can look like a wall of abbreviations and numbers, but it is frequently the most clinically important part of the report. MedlinePlus has plain-language explanations for many of the individual tests you'll see listed.

Staging information. If staging is included, it usually reflects how far the condition has progressed. Staging affects nearly every treatment decision that follows. The NCI overview of cancer staging explains the common systems in everyday language.

Comment or note. Sometimes the pathologist adds context — cases that were close calls, additional testing they recommend, or clarifications for the treating doctor. Worth reading; often the most human-language part of the report.

The terms that carry the most weight

A handful of words show up in almost every cancer pathology report and drive most of the treatment decisions. If you understand these, you understand roughly 80% of what the report is telling you.

Invasive vs. in situ. In situ ("in place") means the abnormal cells are still contained in the layer where they started — they haven't grown into surrounding tissue. Invasive means they've broken out. In situ disease is generally treated less aggressively than invasive disease.

Grade. How abnormal the cells look under the microscope and how quickly they're likely to grow. Grade 1 (well differentiated) means cells still look mostly normal. Grade 3 (poorly differentiated) means they've lost most of their normal features and often grow faster. Grade is different from stage — grade is about the cells themselves; stage is about how far the disease has spread.

Margins. The edges of the tissue removed by the surgeon. Clear (or negative) margins mean no abnormal cells were seen at the edge, suggesting the surgeon got all the visible disease. Positive (or involved) margins mean cells were present right at the edge, and additional treatment — more surgery, radiation, or both — may be needed. Close margins are a gray zone that your doctor will interpret.

Lymphovascular invasion (LVI). Whether cancer cells were seen inside small blood or lymph vessels near the tumor. Positive LVI can suggest higher risk of spread.

Nodes. If lymph nodes were removed, the report will say how many were examined and how many contained cancer (e.g. "2 of 15 nodes positive"). Node status is a major driver of stage and treatment.

Receptor status (breast cancer especially). ER+ and PR+ (estrogen and progesterone receptor positive) mean hormone therapies will likely work. HER2+ means HER2-targeted drugs like trastuzumab are options. Triple negative (ER-, PR-, HER2-) rules out those specific therapies but doesn't rule out treatment — it just means a different set of options.

Ki-67. A measure of how quickly cells are dividing. Higher numbers usually mean faster-growing disease.

What the report usually does not tell you

A pathology report describes what was found. It does not explain:

• What to do about it
• What your specific treatment options are
• What your prognosis is
• What questions you should be asking

That interpretation happens in conversation with your care team — and it's reasonable to ask for that conversation to happen slowly enough that you actually understand it.

If a term is unfamiliar, ask specifically

The most useful question you can ask isn't "What does this all mean?" It's more surgical:

• "What does this specific word mean in my case?"
• "Which parts of this report drove your treatment recommendation?"
• "Is anything on this report borderline or open to interpretation?"
• "Should this be reviewed by a second pathologist?"

For anything cancer-related, a second pathology review at a major cancer center is common and often changes details of the diagnosis. If a second opinion would help, the NCI's guidance on getting one is a good place to start.

If you're staring at a report right now

You don't have to wait for your next appointment to start making sense of it. Paste in what your report says and Cura will walk through it in plain language — line by line — and generate the specific follow-up questions worth bringing to your care team. Not a generic checklist. The questions that actually match what's on your paper.

Ask Cura about your report →

Related reading

• What to ask after a breast cancer diagnosis — where your pathology report matters most in the first days after diagnosis.
• Questions to ask after any new diagnosis — the broader framework for the appointment where you'll discuss this report.
• What to ask after a heart disease diagnosis — a different disease area, same principle of asking about the underlying test results.

---

This post is for general informational purposes and isn't a substitute for guidance from your care team. Always confirm interpretation of your specific report with the physician who ordered it.